Выберите регион
Отправить

Подпишитесь на нашу новостную ленту

Подписаться

06.11.2024
Contributing to a legacy of life-saving technology

Meet Carl Famulare, a technical associate and long-time member of the Getinge family who recently participated in Getinge’s 2024 company video highlighting the purpose to make life-saving technology accessible for more people.

28.10.2024
Paragonix Technologies receives FDA 510(k) clearance for KidneyVault portable renal perfusion system

Paragonix Technologies, a leading organ preservation company recently acquired by Getinge, receives FDA clearance for the innovative transportable perfusion device KidneyVault, to optimize standard of care in kidney preservation.

18.10.2024
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

“The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased by 3.5%, of which the organic increase was 0.2%, while the operating margin weakened compared with last year.

09.10.2024
FleetView by Getinge elevates service with connected devices

Building on over 15 years of experience in connected devices, Getinge now introduces FleetView. This web application represents the next step in data-driven device lifecyle management, offering healthcare providers and life science companies a tool to navigate large amounts of service data and statistical insights. Providing a vehicle to access the insights needed to optimize operational efficiency, FleetView is not only positioned to help customers reduce total cost of ownership but also helps enhance service reliability and uptime.  

04.10.2024
Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call

Getinge will issue its Q3 Report 2024 on October 18, 2024, at 08:00 a.m. CEST, followed by a conference call at 10.00-11.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

25.09.2024
Getinge’s CE certificate for ECLS consumables reinstated

The notified body, TÜV SÜD, reinstates Getinge’s CE certificate for HLS and PLS consumables, used for ECLS therapy, with certain conditions. Temporary challenges with a supplier and production changeover related to the new packaging solution have resulted in a lower volume of HLS and PLS sets available for shipment in Q3 2024, which is expected to be phased into Q4 2024.

Пресс-контакт

Lars Mattsson

Interim EVP Brand & Communication
Phone: +46 10 335 0043

Caroline Örmgård

Head of Public & Media Relations
Phone: +46 10 335 0041

Katarzyna Sypuła

Head of Marketing Communications CEE/MEA
Tel: +48 661 705 706

Newsroom2

Предпочитаете связаться с нами онлайн?

Нажмите ниже, чтобы заполнить соответствующую форму. Мы свяжемся с вами в ближайшее время!

Вы ищете

Getinge Hybrid OR

Галерея

Разнообразный формат изображений доступен для статей в прессе

Man and woman looking a something together

О нас

Все, что вам нужно знать о Getinge одним взглядом

Cardiosave

Срочная коррекция медицинского оборудования

Добровольная срочная полевая коррекция медицинского устройства для внутриаортальной баллонной контрпульсации CARDIOSAVE (IABP)

Newsroom

Не пропустите ничего

Кликайте на иконки и подписывайтесь на нас!